Autopsy report · NCT05436509
CD19/79b Bi-specific CAR-T Cell Therapy
Cause of deathNo reason given
Life of this trial
- Registered 3 years 11 months before it started.
- Ran for about 2 months before it stopped.
- 60 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Sponsor type
- University, hospital or other
- Conditions
- B Cell Malignancies
- Interventions
- bi-4SCAR CD19/79b T cells
- Participants
- 60
- Sites
- 1
- Countries
- China
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.